June 8 (Reuters) – Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. (Reporting by Puyaan Singh in Bengaluru;
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
'Gentle Monster': Child abuse drama gets release after Cannes debut
In the drama "Gentle Monster", Jella Haase investigates a case of child abuse and shares…
Apple joins foldable phone race with $1,999 passport-shaped iPhone Duo
By Stephen Nellis and Kenrick Cai CUPERTINO, California, Sept 9 (Reuters) - Apple on Wednesday…
Macy's raises annual targets as Bloomingdale's drives growth
Sept 10 (Reuters) - Macy's raised its annual sales and profit forecasts on Thursday after…
